Dinoprostone is used as a uterine stimulant for labor induction at term, second-trimester pregnancy termination, therapeutic abortion, and preoperative cervical ripening; it induces cervical ripening and labor, mediates bradykinin-induced vasodilation, regulates adenylate cyclase activity; PGE2 promotes angiogenesis and anti-apoptotic effects in COX-2-overexpressing tumor cells via upregulation of angiogenic factors and stabilization of survivin; it exhibits dual immunomodulatory effects—suppressing T-cell activation in vitro (indicating immunosuppressive activity) while promoting Th17 expansion and Th1 differentiation in vivo (indicating immune-activating properties).